PALM SPRINGS, Fla.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/EyeExam?src=hash" target="_blank">#EyeExam</a>–Mike Wootton, Joe Malmuth, and William Reno Lead My Eyelab Business Opportunity’s National Growth…
Category: Business
American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon announces that the American Journal of Ophthalmology has published a review highlighting the lack of treatments for active thyroid eye disease
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
GENEVA–(BUSINESS WIRE)–Alcon Launches New PRECISION1 Contact Lenses that Deliver Superior Performance Over #1 Selling Daily Disposable
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
GENEVA–(BUSINESS WIRE)–Alcon Launches New PRECISION1 Contact Lenses that Deliver Superior Performance Over #1 Selling Daily Disposable
CLARIUM Lens Launches a Wider Range of Premium Quality Lens Products
SINGAPORE–(BUSINESS WIRE)–Clarium Lens, a technological innovator in the field of optics, extends its range of Clarium Lux lens products. The Clarium Lux range is designed to address the growing number of vision problems that limit visual perception….
Quidel Reports Second Quarter 2019 Financial Results
SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 20…
BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank">$BTX</a> <a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank">#AMD</…
Omeros Corporation Reports Second Quarter 2019 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications ta…
Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s new drug application (NDA) for KPI-1…
Glaukos Corporation Announces Second Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Glaukos Corporation Announces Second Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Glaukos and Avedro Announce Definitive Acquisition Agreement
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nas…
Glaukos and Avedro Announce Definitive Acquisition Agreement
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nas…
Ocular Therapeutix™ Reports Second Quarter 2019 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX…
Aerie Pharmaceuticals Reports Second Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aerie Pharmaceuticals Reports Second Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Ocular Therapeutix™ Reports Second Quarter 2019 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX…
NuSight Medical Sells 5,000 NuLids Systems
RANCHO SANTA FE, Calif.–(BUSINESS WIRE)–Sale of 5,000 NuLids supports doctors and patients belief and value in NuLids
IVERIC bio to Present at the Wedbush PacGrow Healthcare Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Glenn P. Sblendorio, CEO & President, will present an overview of the Company at the Wedbush PacGrow Healthcare Conference.
Second Sight Reports Second Quarter 2019 Financial Results
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…